©The Author(s) 2025.
World J Diabetes. Sep 15, 2025; 16(9): 107517
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.107517
Published online Sep 15, 2025. doi: 10.4239/wjd.v16.i9.107517
Table 2 Classification of adiposity-induced metabolic dysfunction associated disease
| Classification of adiposity-induced metabolic dysfunction associated disease |
| Metabolic dysfunction associated endocrine diseases |
| Metabolic dysfunction associated hyperglycemic diseases |
| Metabolic dysfunction associated cardiovascular diseases |
| Metabolic dysfunction associated gastrointestinal diseases |
| Metabolic dysfunction associated hepatobiliary diseases |
| Metabolic dysfunction associated fatty liver diseases/metabolic dysfunction associated steatotic liver diseases |
| Metabolic dysfunction associated neurological diseases |
| Metabolic dysfunction associated genitourinary diseases |
| Metabolic dysfunction associated circulatory diseases |
| Metabolic dysfunction associated respiratory diseases |
| Metabolic dysfunction associated musculoskeletal diseases |
| Metabolic dysfunction associated immune diseases |
| Metabolic dysfunction associated sexual diseases/dysfunction |
| Metabolic dysfunction associated integumentary diseases |
- Citation: Raveendran AV. Type 2 diabetes mellitus: Isn’t it time to update the terminology? World J Diabetes 2025; 16(9): 107517
- URL: https://www.wjgnet.com/1948-9358/full/v16/i9/107517.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i9.107517